107 related articles for article (PubMed ID: 26979953)
1. Exploring the surfaceome of Ewing sarcoma identifies a new and unique therapeutic target.
Town J; Pais H; Harrison S; Stead LF; Bataille C; Bunjobpol W; Zhang J; Rabbitts TH
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3603-8. PubMed ID: 26979953
[TBL] [Abstract][Full Text] [Related]
2. The Ewing Sarcoma Secretome and Its Response to Activation of Wnt/beta-catenin Signaling.
Hawkins AG; Basrur V; da Veiga Leprevost F; Pedersen E; Sperring C; Nesvizhskii AI; Lawlor ER
Mol Cell Proteomics; 2018 May; 17(5):901-912. PubMed ID: 29386236
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Hope on the Surface of Ewing Sarcoma.
Bailey KM
Clin Cancer Res; 2024 Mar; 30(5):934-936. PubMed ID: 38113033
[TBL] [Abstract][Full Text] [Related]
4. The in silico human surfaceome.
Bausch-Fluck D; Goldmann U; Müller S; van Oostrum M; Müller M; Schubert OT; Wollscheid B
Proc Natl Acad Sci U S A; 2018 Nov; 115(46):E10988-E10997. PubMed ID: 30373828
[TBL] [Abstract][Full Text] [Related]
5. Surfaceome mapping of primary human heart cells with CellSurfer uncovers cardiomyocyte surface protein LSMEM2 and proteome dynamics in failing hearts.
Luecke LB; Waas M; Littrell J; Wojtkiewicz M; Castro C; Burkovetskaya M; Schuette EN; Buchberger AR; Churko JM; Chalise U; Waknitz M; Konfrst S; Teuben R; Morrissette-McAlmon J; Mahr C; Anderson DR; Boheler KR; Gundry RL
Nat Cardiovasc Res; 2023 Jan; 2(1):76-95. PubMed ID: 36950336
[TBL] [Abstract][Full Text] [Related]
6. Elucidating the Cell Surfaceome to Accelerate Cancer Drug Development.
Geri JB; Pao W
Cancer Discov; 2024 Apr; 14(4):639-642. PubMed ID: 38571413
[TBL] [Abstract][Full Text] [Related]
7. Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1.
Jacques C; Lamoureux F; Baud'huin M; Rodriguez Calleja L; Quillard T; Amiaud J; Tirode F; Rédini F; Bradner JE; Heymann D; Ory B
Oncotarget; 2016 Apr; 7(17):24125-40. PubMed ID: 27006472
[TBL] [Abstract][Full Text] [Related]
8. Investigational therapies for Ewing sarcoma: a search without a clear finding.
Vornicova O; Bar-Sela G
Expert Opin Investig Drugs; 2016 Jun; 25(6):679-86. PubMed ID: 26988130
[TBL] [Abstract][Full Text] [Related]
9. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
Andersson C; Fagman H; Hansson M; Enlund F
Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
[TBL] [Abstract][Full Text] [Related]
10. An EWS-FLI1-Induced Osteosarcoma Model Unveiled a Crucial Role of Impaired Osteogenic Differentiation on Osteosarcoma Development.
Komura S; Semi K; Itakura F; Shibata H; Ohno T; Hotta A; Woltjen K; Yamamoto T; Akiyama H; Yamada Y
Stem Cell Reports; 2016 Apr; 6(4):592-606. PubMed ID: 26997645
[TBL] [Abstract][Full Text] [Related]
11. Molecular Heterogeneity of Ewing Sarcoma as Detected by Ion Torrent Sequencing.
Zhang N; Liu H; Yue G; Zhang Y; You J; Wang H
PLoS One; 2016; 11(4):e0153546. PubMed ID: 27077911
[TBL] [Abstract][Full Text] [Related]
12. SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration.
Indovina P; Casini N; Forte IM; Garofano T; Cesari D; Iannuzzi CA; Del Porro L; Pentimalli F; Napoliello L; Boffo S; Schenone S; Botta M; Giordano A
J Cell Physiol; 2017 Jan; 232(1):129-35. PubMed ID: 27037775
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional Radiologic Assessment of Chemotherapy Response in Ewing Sarcoma Can Be Used to Predict Clinical Outcome.
Aghighi M; Boe J; Rosenberg J; Von Eyben R; Gawande RS; Petit P; Sethi TK; Sharib J; Marina NM; DuBois SG; Daldrup-Link HE
Radiology; 2016 Sep; 280(3):905-15. PubMed ID: 26982677
[TBL] [Abstract][Full Text] [Related]
14. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
[TBL] [Abstract][Full Text] [Related]
15. Integration with Transcriptomic and Metabolomic Analyses Reveals the
Guo Y; Liu Z; Wu Q; Li Z; Yang J; Xuan H
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892405
[TBL] [Abstract][Full Text] [Related]
16. Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma.
Mooney B; Negri GL; Shyp T; Delaidelli A; Zhang HF; Spencer Miko SE; Weiner AK; Radaoui AB; Shraim R; Lizardo MM; Hughes CS; Li A; El-Naggar AM; Rouleau M; Li W; Dimitrov DS; Kurmasheva RT; Houghton PJ; Diskin SJ; Maris JM; Morin GB; Sorensen PH
Clin Cancer Res; 2024 Mar; 30(5):1022-1037. PubMed ID: 37812652
[TBL] [Abstract][Full Text] [Related]
17. Targeted Therapy for EWS-FLI1 in Ewing Sarcoma.
Gong H; Xue B; Ru J; Pei G; Li Y
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627063
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Potential Targets for Fluorescence-Guided Surgery in Pediatric Ewing Sarcoma: A Preclinical Proof-of-Concept Study.
Jeremiasse B; Rijs Z; Angoelal KR; Hiemcke-Jiwa LS; de Boed EA; Kuppen PJK; Sier CFM; van Driel PBAA; van de Sande MAJ; Wijnen MHWA; Rios AC; van der Steeg AFW
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568714
[TBL] [Abstract][Full Text] [Related]
19. A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myeloma.
Di Meo F; Iyer A; Akama K; Cheng R; Yu C; Cesarano A; Kurihara N; Tenshin H; Aljoufi A; Marino S; Soni RK; Roda J; Sissons J; Vu LP; Guzman M; Huang K; Laskowski T; Broxmeyer HE; Roodman DG; Perna F
Cell Rep Med; 2023 Jul; 4(7):101110. PubMed ID: 37467717
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
